Japan's Nichi-Iko Teams With Sanofi-Aventis For Joint Generic Venture
This article was originally published in PharmAsia News
Executive Summary
Nichi-Iko Pharmaceutical of Japan reportedly has agreed to collaborate with France's Sanofi-Aventis for producing generic drugs for the Japanese market